CF Industries: The Stock Slipped on a Miss. The Cash Flow Story Didn't.

CF Industries shares have dropped 8.7% over the past five days, wiping roughly $1.5 billion off the market cap. The catalyst was straightforward enough: on August 5, the company reported second-quarter EPS of $4.73 and revenue of $2.22 billion, both below Wall Street consensus estimates of $5.63 and $2.45 billion. The headline write-ups led with the miss. The market priced it like a deterioration.

Let me start with what the quarterly numbers actually show, because the headline framing misses the point.

CF Industries generated $727 million in net earnings for the quarter, up 88% year-over-year from $386 million. Adjusted EBITDA — earnings before interest, taxes, depreciation, and amortization, a rough proxy for cash earnings — rose 57% to $1.19 billion. Gross margin expanded to 51.5%, up 11.6 percentage points from a year ago. The company produced $2.98 billion in trailing-12-month operating cash flow and $1.82 billion in free cash flow. That is not the cash-flow profile of a business in trouble. It is the cash-flow profile of a business pricing power that just re-accelerated.

The miss came from volume, not margin. Sales volume fell roughly 15% year-over-year, from 5.02 million tons to 4.25 million tons. Part of that reflects the Yazoo City complex, which remains idled and is not expected to restart until the first half of 2027. Even excluding Yazoo City, volumes were still about 9% below the prior-year period. Higher prices more than compensated — ammonia average selling price rose roughly 50% to $677 per ton; granular urea rose 29% to $593 per ton. But analysts had built in higher volume into their models. When volume disappoints, revenue and EPS follow, even if unit economics are better than anyone expected.

The competitor headline also invoked project delays. That framing doesn't match the facts on the ground. The $4 billion Blue Point low-carbon ammonia joint venture — a partnership with Japanese energy firms JERA and Mitsui to build the world's largest low-carbon ammonia facility in Louisiana — received its final permits in July 2026. Construction is scheduled to begin this month, August 2026. The project targets 1.5 million metric tons of ammonia capacity by late 2029. There is no delay at Blue Point. If anything, the timeline is moving ahead. CF's own share of 2026 capital expenditure is about $950 million, with total consolidated capex around $1.3 billion.

Now let's talk about valuation, because that is where the real story lives.

CF Industries trades at 8.2 times trailing earnings and 4.5 times trailing EV/EBITDA. Its peer Mosaic — the other major U.S. fertilizer producer — carries negative trailing earnings and trades at 13.4 times EV/EBITDA, even as it struggles with profitability. CF's return on invested capital is 22.3%. Its return on equity is 39.2%. The company has $2.48 billion in cash against $6.18 billion in total debt, for net debt of just $736 million. Debt-to-equity sits at 36%. The current ratio is 486%, meaning CF could cover its current liabilities nearly five times over with current assets alone. The balance sheet is not a concern.

From a cash-flow durability perspective, the business is remarkably strong. CF has returned nearly $1.3 billion to shareholders over the past 12 months — $958 million in buybacks and $314 million in dividends. The quarterly dividend was just raised 20% to $0.60 per share, extending a streak of 20 consecutive years of dividend payments. The trailing payout ratio is 18%, which leaves enormous room for both growth and resilience. Free cash flow of $1.82 billion more than covers the dividend spend of roughly $465 million annualized at the new rate.

Here is what the market is misreading. The sell-off treated a volume miss as a margin threat. It treated a one-quarter shortfall against an aggressive consensus as structural weakness. It conflated a temporary supply-demand dynamic — nitrogen prices returning to pre-conflict levels at the end of Q2 as Northern Hemisphere seasonal demand wound down and Middle East production came back online — with a secular downturn. The company itself sees the global nitrogen market staying tight into 2027, citing constrained supply growth, high LNG costs pressuring marginal producers, and deferred demand in Brazil and India.

Management also raised its mid-cycle EBITDA target. The baseline expectation was approximately $2.9 billion. Strategic initiatives — including Blue Point, low-carbon ammonia premium pricing (which already accounted for roughly 10% of first-half ammonia volumes at a $20-plus-per-ton premium), and ongoing network optimization — push that target to approximately $3.3 billion by 2030.

While it's true that nitrogen prices have cooled from their mid-2026 peaks, the underlying structure of the market has not changed. CF's North American cost advantage, its high utilization rate (nearly 98% of available ammonia capacity in the first half), and its $3.37-per-MMBtu natural gas cost base create a margin floor that most global producers cannot match. The Iran conflict removed an estimated 4 to 4.5 million metric tons of urea and 1 million metric tons of ammonia from traded supply. Even if geopolitical tensions ease, replacement capacity takes years to build.

All things considered, CF Industries remains fantastically undervalued. A stock generating nearly 3% operating cash flow on an enterprise value of $18 billion, trading at 4.5 times EBITDA, with a net debt load of $736 million and a payout ratio of 18%, does not deserve an 8.7% haircut over five days. The earnings miss was a volume story, not a margin story. The project narrative is backward — Blue Point is advancing, not delayed. And the peer comparison to Mosaic shows how deeply the market has discounted CF relative to a competitor that can't even report positive earnings.

Even if nitrogen prices normalize further and volumes lag for another quarter or two, the cash-flow cushion is wide enough to absorb it. Free cash flow covers the dividend by a factor of nearly four. The balance sheet gives management optionality to buy back shares at attractive prices. And Blue Point construction starting this month is the first physical step toward a $3.3 billion mid-cycle EBITDA floor that the market has not yet priced in.

I reaffirm my Strong Buy rating.

The risk to this view is straightforward: if Iran-related supply disruptions fully resolve and new capacity comes online faster than expected, nitrogen prices could re-rate lower, compressing CF's margins below current levels. That would hurt near-term earnings. But at 4.5 times EV/EBITDA with a 22% return on invested capital, the margin of safety is built in. The market is pricing in a story that the cash flows don't support.